Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Svennilson Peter
Relationship:   Director, 10% Owner
City:   Seattle
State:   WA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   21,988,435    

Indirect Shares

   28,546,447      
Direct Value   $116,365,202    

Indirect Value

   $274,329,670      
Total Shares   50,534,882      
Total Value   $390,694,873      


Constellation Pharmaceuticals Inc $87,862,688 Ngm Biopharmaceuticals Inc $27,702,818 Revolution Medicines, Inc. $799,696 Nurix Therapeutics, Inc. $0 Constellation Pharmaceuticals Inc $87,862,688 Ngm Biopharmaceuticals Inc $27,702,818 Revolution Medicines, Inc. $799,696 Nurix Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    32   
    4    

     Stock price went up :
    32   
    1    
     Stock price went down :
    0   
    3    
   
     Gain/Loss Ratio :
   32.0   
   32.0   
     Percentage Gain/Loss :
   66.6%
 -51.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Immune Design Corp. IMDZ Managing Partner, 10% ... 2019-04-02 0 2017-10-27 6,642,942    Premium*  
            Constellation Pharmaceuticals Inc CNST 10% Owner 2021-02-17 2,584,957 2021-02-17 3,645,681    Premium*  
            Gritstone Oncology, Inc. GRTS Director, 10% Owner 2018-10-02 0 2018-10-02 3,102,934    Premium*  
            Ngm Biopharmaceuticals Inc NGM Managing Partner, 10% ... 2020-08-28 17,988,843 2020-08-28 190,000    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Director, 10% Owner 0 2020-04-28 4,768,181    Premium*  
            Revolution Medicines, Inc. RVMD Director 2021-04-28 20,302 2021-04-28 3,145,258    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2021-05-05 1,394,333 2021-05-05 1,420,954    Premium*  
            Rapt Therapeutics, Inc. RAPT Director, 10% Owner 2020-08-17 0 2020-09-22 5,630,497    Premium*  
* Premium Members only  

Records found :    116         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
IMDZ Immune Design Corp. Director   –       •       •   2014-07-29 4 A $0.00 $0 I/I 2,762,926 2,762,926 0 -
IMDZ Immune Design Corp. Director   –       •       •   2014-07-29 4 B $12.00 $4,788,192 I/I 399,016 3,161,942 2.25 -
IMDZ Immune Design Corp. Director   –       •       •   2016-09-20 4 B $6.25 $5,000,000 I/I 800,000 800,000 2.25 -
IMDZ Immune Design Corp. Director   –       •       •   2017-10-27 4 B $4.10 $10,992,100 I/I 2,681,000 2,681,000 2.25 -
CNST Constellation Pharmaceuti... Director   –       •       •   2018-07-23 4 A $0.00 $0 I/I 4,666,888 4,677,939 0 -
GRTS Gritstone Oncology, Inc. Director   –       •       •   2018-10-02 4 A $0.00 $0 I/I 3,102,934 3,102,934 0 -
IMDZ Immune Design Corp. Managing Partner   –       –       •   2019-04-02 4 D $5.85 $38,861,211 D/D (6,642,942) 0 0 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-04-08 4 B $16.00 $320,000 D/D 20,000 20,000 3.92 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-04-08 4 B $16.00 $30,000,000 I/I 1,875,000 2,350,957 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-04-08 4 A $0.00 $0 I/I 13,093,134 15,444,091 0 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-05-07 4 B $14.10 $803,700 I/I 57,000 15,501,091 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-05-10 4 B $13.85 $248,234 I/I 17,923 15,519,014 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-05-20 4 B $13.50 $675,000 I/I 50,000 15,569,014 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-04 4 B $13.39 $168,764 I/I 12,600 15,581,614 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-06 4 B $13.40 $168,884 I/I 12,600 15,594,214 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-07 4 B $13.66 $172,176 I/I 12,600 15,606,814 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-11 4 B $13.83 $150,718 I/I 10,900 15,617,714 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-12 4 B $14.00 $104,989 I/I 7,500 15,625,214 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-13 4 B $14.13 $162,508 I/I 11,500 15,636,714 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-14 4 B $14.00 $150,687 I/I 10,760 15,647,474 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-19 4 B $13.91 $211,674 I/I 15,214 15,662,688 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-20 4 B $13.86 $213,385 I/I 15,400 15,678,088 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-21 4 B $14.03 $52,789 I/I 3,763 15,681,851 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-24 4 B $13.78 $168,650 I/I 12,240 15,694,091 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-11 4 B $13.87 $150,752 I/I 10,870 15,704,961 2.25 -
  116  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us